• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The microRNA expression in lymph node metastasis of gastric cancer

Research Project

Project/Area Number 24791439
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Digestive surgery
Research InstitutionNational Cancer Center Japan (2013-2014)
Fukushima Medical University (2012)

Principal Investigator

SAITO Motonobu  独立行政法人国立がん研究センター, 研究所, 研究員 (90611749)

Project Period (FY) 2012-04-01 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2014: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2013: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Keywords胃癌 / CDX2 / マイクロRNA / 炎症発癌 / 胃癌リンパ節転移 / リンパ節転移
Outline of Final Research Achievements

We confirmed that decreased expression of CDX2 by immunohistochemistry was associated with poor cancer-specific survival in our 210 gastric cancer cases, consistent with several previous studies. We further investigated the mechanisms of CDX2 suppression, including the IL-6/STAT3 and p53 pathways. We confirmed that CDX2 was suppressed by activation of the IL-6/STAT3 pathway via miR-181b in vitro. We further revealed that gastric cancers, particularly those that are undifferentiated, with CDX2-negative expression are associated with p53-negative staining. The activation of the IL-6/STAT3 pathway suppressed miR-34a, which is induced by p53, suggesting that the activation of this inflammation signaling pathway suppresses the p53 pathway in tumors without TP53 mutation, resulting in poor prognostic outcome. In conclusion, the activation of the IL-6/STAT3 pathway contributes to gastric carcinogenesis through suppression of CDX2 and inactivation of p53, resulting in poor prognostic outcome.

Report

(4 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report
  • 2012 Research-status Report

Research Products

(4 results)

All 2018 2017 2013

All Journal Article Presentation

  • [Journal Article] ZIC5 drives melanoma aggressiveness by PDGFD-mediated activation of FAK and STAT3.2018

    • Author(s)
      Hiraga T, Myoui A, Hashimoto N, Sasaki A, Hata K, Morita Y, Yoshikawa H, Rosen CJ, Mundy GR, Yoneda T.
    • Journal Title

      Cancer reserach

      Volume: 72(16) Pages: 1283-1295

    • Related Report
      2013 Research-status Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Dual inhibition of EZH2 and EZH1 sensitizes PRC2-dependent tumors to proteasome inhibition.2017

    • Author(s)
      Harada T, Yatabe Y, Takeshita M, Koga T, et al
    • Journal Title

      Anticancer Res

      Volume: 17 Pages: 1114-1114

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] NOS2 enhances KRAS-induced lung carcinogenesis, inflammation and microRNA-21 expression2013

    • Author(s)
      Okayama H, Saito M, Oue N, Weiss JM, Stauffer J, Takenoshita S, Wiltrout RH, Hussain SP, Harris CC.
    • Journal Title

      International Journal of Cancer

      Volume: 132 Pages: 9-18

    • DOI
      10.1002/ijc.27644
    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Presentation] 胃癌におけるCDX2遺伝子発現とその意義2013

    • Author(s)
      齋藤元伸、岡山洋和、隈元謙介、中村泉、大木進司、石井芳正、野水整、竹之下誠一
    • Organizer
      第85回日本胃癌学会
    • Place of Presentation
      大阪国際会議場
    • Related Report
      2013 Research-status Report

URL: 

Published: 2013-05-31   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi